Montelukast Sodium Tablet, Chewable
Product Images NDC 13668-080

The text seems to be a chart that shows the change in height (in centimeters) for two groups of people, one with 130 subjects who were on a treatment called "Monseliéas Soden § g" and another group of 121 subjects who were on a placebo. The chart also displays the duration of treatment in weeks. There is some strange text in the beginning that says "bbho-pwsaa" and some numbers that could be a date (1624) and a percentage (5%). Overall, it seems like a medical or scientific study on the effects of a drug on height.*

The text seems to represent a table or a graph displaying the mean percent change from baseline for different weeks in the treatment of placebo and Montelukast Socium. The timeframe mentioned is from 2 to 15 weeks, but without additional context, it is difficult to determine the purpose of this data.*

Each tablet contains 4.2 mg montelukast sodium, USP equivalent to 4 mg of montelukast. These are chewable tablets for pediatric patients aged 2-5 years old. It is advised to store them in the original container, away from moisture and light, at a controlled room temperature of 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The prescription should come with a patient information sheet and dispensed in a tight, light-resistant container. It is manufactured by Torrent Pharmaceuticals LTD, India and contains phenylalanine (0.168 mg per 4-mg chewable tablet) for phenylketonurics.*

This is a description for a medication containing 4.2 milligrams of montelukast in each tablet. The tablets are chewable and intended for pediatric patients aged 2 to 5 years. The medication should be stored in a container at 20-25°C and protected from moisture and light. Dispensing pharmacist should provide the accompanying prescribing and patient information sheet to each patient. The medication contains phenylalanine, a component of aspartame, and therefore contains 0.168 mg per 4-mg chewable tablet. It is manufactured by Torrent Pharmaceuticals Ltd. in Bharuch-302130, India for Torrent Pharma Inc. The NDC number is 13663-079-30, and the product code is 8082767.*

This is a bottle of Montelukast Sodium Chewable Tablets, USP, with 30 tablets, manufactured by Torrent Pharmaceuticals LTD, India. Each tablet contains 5.2 mg of Montelukast Sodium, equivalent to 5 mg of Montelukast, and is meant for pediatric patients between the ages of 6 and 14. The tablets should be stored in the original container at temperatures between 20° and 25°C, with excursions permitted to 15° to 30°C. Pharmacists should dispense the accompanying Patient Information Sheet to each patient. The tablets should be protected from moisture, light and dispensed in a tight, light-resistant container with a child-resistant closure. The product is Rx only and phenylketonurics should take note that the tablet contains phenylalanine.*

This is a description of a medication called Montelukast Sodium Chewable Tablets, USP. It is typically used for pediatric patients aged between 6 and 14 years of age. It comes in a 30 tablet package (NDC 13668-080-30) and each tablet contains 5.2 mg of montelukast sodium, USP equivalent to 5 mg of montelukast. The tablets should be stored at temperatures between 20° to 25°C (68° to 77°F) but excursions up to 15° to 30°C (59° to 86°F) are permitted. The medication should be stored in its original container and must be protected from moisture and light. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. This pharmaceutical is manufactured by Torrent Pharmaceuticals LTD in Bharuch-392130, INDIA, and is manufactured for Torrent Pharma Inc. in Levittown, PA 19057. The prescription is only available to patients with a physician's prescription. The package also includes a warning that it contains phenylalanine, a component of aspartame, and a Patient Information Sheet should be provided to each patient.*

Each tablet contains 10.4 mg montelukast sodium USP equivalent to 10 mg of montelukast. It is recommended to store this medication at room temperature between 20° to 25°C (68° to 77°F) and in its original container with excursions permitted from 0 15° to 30°C (59° to 86°F). Protect tablets from moisture and light and dispense in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Torrent Pharmaceuticals Ltd, India and manufactured for Torrent Pharma Inc., Levittown, PA 19057. Mig. Lic. No.: G926, 30Tablets with NDC 13668-081-30. Montelukast Sodium Tablets, USP is for use in adults aged 15 years and older. A patient information sheet should be given to each patient. Rx only.*

Montelukast Sodium Tablets, USP is a medication used to treat asthma and seasonal allergies in people over 15 years of age. Each tablet contains 10.4 mg of montelukast sodium. It is advised to store the medication at 20° to 25°C (68° to 77°F), with permitted excursions of 0 15° to 30°C (59° to 86°F) and in the original container, protected from moisture and light. Dispense the medication in a tight, light-resistant container with a child-resistant closure. Usual dosage information can be found in the accompanying prescribing information. The manufacturing and distribution of the medication is done by TORRENT PHARMACEUTICALS LTD., Bharuch-302130, INDIA, and TORRENT PHARMIA INC., Levtiown, PA 19057 respectively.*

This is a medication called Montelukast Sodium which comes in the form of oral granules used for pediatric patients between 6 months to 5 years old. It is sold in a pack of 30 sachets and is only available with a prescription. The provided text contains two slightly different versions of the medication, but most of the information is the same.*